Direct Bilirubin - India CDSCO Medical Device Registration

Direct Bilirubin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000861_de87e990dd1cf4ee1cc10bc45eddd7af_ce86b963476d5c4b890670a0a9d8d897. This device is marketed under the brand name quantILab. The license holder is Instrumentation Laboratory India Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

Direct Bilirubin

UID: IMP/IVD/2020/000861_de87e990dd1cf4ee1cc10bc45eddd7af_ce86b963476d5c4b890670a0a9d8d897

Brand Name

quantILab

License Holder

Instrumentation Laboratory India Pvt Ltd

Device Class

Class B

Approving Authority

CDSCO

Product Information

Direct Bilirubin assay is intended for the quantitative in vitro diagnostic determination of direct bilirubin in human serum and plasma using the ILab Chemistry Systems

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Direct Bilirubin

NEXOGENIX LIFESCIENCES LLP

Class B

Brand: quantILab

Instrumentation Laboratory India Pvt Ltd

Class B

Brand: quantILab

Class B